🇺🇸 FDA
Patent

US 7498336

Deazaflavin compounds and methods of use thereof

granted A61PA61P35/00

Quick answer

US patent 7498336 (Deazaflavin compounds and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P35/00